Ontology highlight
ABSTRACT:
SUBMITTER: Loyd I
PROVIDER: S-EPMC9268110 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Loyd India I Papac Nicole N Hirshburg Jason J Levin Jarad J Dannelley Jennifer J Dorris Janislynn J Stratton Jason J Mehdi Nighat N
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20220706 5
Adverse reactions, including severe cutaneous reactions, to cystic fibrosis transmembrane conductance regulator (CFTR) modulators have been described in the literature. Herein we present a drug eruption in response to elexacaftor/tezcaftor/ivacaftor (brand name, Trikafta) in a 7-year-old male with cystic fibrosis, followed by desensitization and successful continuation. A review of the literature outlining similar cases is provided. Attempting to mitigate and manage drug reactions to CFTR modula ...[more]